"Nikhilesh joins us at a time when we are building strong presence in consumer healthcare in India, with the recent closure of business swap with Boeringher Ingelheim and its incoming CHC brands.
"We plan to accelerate the growth of our CHC business in India and South Asia," Sanofi managing director - India and vice president - South Asia Shailesh Ayyangar said in a statement here.
The consumer health space has great opportunity in South Asia, and Sanofi is amongst the top consumer healthcare companies in the world. In India, Sanofi has a long history with well-loved and trusted brands like Combiflam and Avil.
"I look forward to growing these brands further, and strengthen Sanofi's position in the consumer health space in India and in South Asia," Kalra said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
